GSK-2983559 | B2709

GSK-2983559 is a potent and selective inhibitor of receptor interacting protein-2 (RIP2) kinase.

GSK-2983559 is a potent and selective inhibitor of receptor interacting protein-2 (RIP2) kinase.

B2709 | GSK-2983559 DataSheet

Alternate Name/Synonyms: 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate,GSK2983559

Appearance: Crystalline solid

Formulation:

CAS Number: 1579965-12-0

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₁H₂₃N₄O₇PS₂

Molecular Weight: 538.53

Cell-Permeable?: TRUE

Purity: ≥98% by HPLC

Solubilities: ~5 mg/ml DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A small-molecule RIP2 kinase inhibitor

MDL Number:

PubChem CID: 73386708

SMILES: CC(C)(C)S(=O)(=O)C1=C(C=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)SC=N4)OCCOP(=O)(O)O

InChi: InChI=1S/C21H23N4O7PS2/c1-21(2,3)35(29,30)19-9-14-15(10-17(19)31-6-7-32-33(26,27)28)22-11-23-20(14)25-13-4-5-18-16(8-13)24-12-34-18/h4-5,8-12H,6-7H2,1-3H3,(H,22,23,25)(H2,26,27,28)

InChi Key: MJLYDVMFNHZMLV-UHFFFAOYSA-N